News & Updates
Filter by Specialty:
Shorter treatment regimen feasible for rifampin-resistant TB?
Individuals with rifampin-resistant tuberculosis (RR-TB) may have the option to undergo shorter treatment periods, as findings from the phase II/III TB-PRACTECAL* trial show the noninferiority and superiority of a 24-week, all-oral regimen to standard of care (SoC). It also had a better safety profile than SoC.
Shorter treatment regimen feasible for rifampin-resistant TB?
13 Feb 2023T2D, orthostatic hypotension up risks of falls, in-hospital mortality
The risk of falls is higher among sedentary patients and those with lower Timed Up and Go test (TUG), according to a study. Patients with type 2 diabetes (T2D) are also at increased risk of falls.
T2D, orthostatic hypotension up risks of falls, in-hospital mortality
12 Feb 2023Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status
Neither vulvovaginal candidiasis nor bacterial vaginosis is associated with increased incidence of cervical cytologic abnormalities among women with or without human papillomavirus (HPV) infection, according to a study. Bacterial vaginosis may even have a protective effect against cytologic abnormalities among women with HPV coinfection.
Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status
11 Feb 2023Metformin lowers HCC risk after antiviral therapy in diabetic patients with hepatitis C
Treatment with metformin results in a significant reduction in hepatocellular carcinoma (HCC) incidence following successful antiviral therapy in individuals with diabetes mellitus and chronic hepatitis C (CHC), a recent study has shown.